Oncomir公司
小RNA
癌症
下调和上调
生物
癌症研究
基因
抑制器
癌细胞
生物标志物
计算生物学
生物信息学
遗传学
作者
Ashutosh Singh,Ashutosh Singh,Rajanish Giri,Dhruv Kumar,Rohit Sharma,Martin Vališ,Kamil Kuča,Neha Garg
出处
期刊:Future Medicinal Chemistry
[Newlands Press Ltd]
日期:2021-09-30
卷期号:13 (21): 1885-1906
被引量:51
标识
DOI:10.4155/fmc-2021-0096
摘要
MicroRNAs (miRNAs), a class of small noncoding RNA, posttranscriptionally regulate the expression of genes. Aberrant expression of miRNA is reported in various types of cancer. Since the first report of oncomiR-21 involvement in the glioma, its upregulation was reported in multiple cancers and was allied with high oncogenic property. In addition to the downregulation of tumor suppressor genes, the miR-21 is also associated with cancer resistance to various chemotherapy. The recent research is appraising miR-21 as a promising cancer target and biomarker for early cancer detection. In this review, we briefly explain the biogenesis and regulation of miR-21 in cancer cells. Additionally, the review features the assorted genes/pathways regulated by the miR-21 in various cancer and cancer stem cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI